Publication Information

{'id': 'https://openalex.org/W2134178274', 'doi': 'https://doi.org/10.1111/j.1365-2125.1995.tb05781.x', 'title': 'Pharmacokinetic‐pharmacodynamic interaction between the COMT inhibitor tolcapone and single‐dose levodopa.', 'display_name': 'Pharmacokinetic‐pharmacodynamic interaction between the COMT inhibitor tolcapone and single‐dose levodopa.', 'publication_year': 1995, 'publication_date': '1995-09-01', 'ids': {'openalex': 'https://openalex.org/W2134178274', 'doi': 'https://doi.org/10.1111/j.1365-2125.1995.tb05781.x', 'mag': '2134178274', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/8527287', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/1365105'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2125.1995.tb05781.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S13842274', 'display_name': 'British Journal of Clinical Pharmacology', 'issn_l': '0306-5251', 'issn': ['0306-5251', '1365-2125'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'green', 'oa_url': 'https://europepmc.org/articles/pmc1365105?pdf=render', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5058093690', 'display_name': 'Jasper Dingemanse', 'orcid': 'https://orcid.org/0000-0002-4083-5817'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'J. Dingemanse', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110032422', 'display_name': 'Karin Jorga', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'K. Jorga', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018337880', 'display_name': 'G. Zürcher', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'G. Zurcher', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109307026', 'display_name': 'Monique Schmitt', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'M. Schmitt', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111626346', 'display_name': 'G Sędek', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'G. Sedek', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110437442', 'display_name': 'M. Da Prada', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'M. Da Prada', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5071530067', 'display_name': 'P. van Brummelen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'P. Van Brummelen', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4330, 'currency': 'USD', 'value_usd': 4330, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.3, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 106, 'citation_normalized_percentile': {'value': 0.947912, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '40', 'issue': '3', 'first_page': '253', 'last_page': '262'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10056', 'display_name': 'Neurotransmitter Receptor Influence on Behavior', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10056', 'display_name': 'Neurotransmitter Receptor Influence on Behavior', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10919', 'display_name': 'Neurological disorders and treatments', 'score': 0.9972, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10085', 'display_name': "Parkinson's Disease Mechanisms and Treatments", 'score': 0.9971, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/entacapone', 'display_name': 'Entacapone', 'score': 0.5945494}, {'id': 'https://openalex.org/keywords/pharmacodynamics', 'display_name': 'Pharmacodynamics', 'score': 0.5251391}, {'id': 'https://openalex.org/keywords/crossover-study', 'display_name': 'Crossover study', 'score': 0.4931957}], 'concepts': [{'id': 'https://openalex.org/C2780304432', 'wikidata': 'https://www.wikidata.org/wiki/Q300989', 'display_name': 'Levodopa', 'level': 4, 'score': 0.83133173}, {'id': 'https://openalex.org/C185361966', 'wikidata': 'https://www.wikidata.org/wiki/Q94291140', 'display_name': 'Catechol-O-methyl transferase', 'level': 4, 'score': 0.82880473}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.8004327}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.6775094}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.60910845}, {'id': 'https://openalex.org/C2776976799', 'wikidata': 'https://www.wikidata.org/wiki/Q416444', 'display_name': 'Entacapone', 'level': 5, 'score': 0.5945494}, {'id': 'https://openalex.org/C2777477808', 'wikidata': 'https://www.wikidata.org/wiki/Q407595', 'display_name': 'Metabolite', 'level': 2, 'score': 0.5580483}, {'id': 'https://openalex.org/C111113717', 'wikidata': 'https://www.wikidata.org/wiki/Q725307', 'display_name': 'Pharmacodynamics', 'level': 3, 'score': 0.5251391}, {'id': 'https://openalex.org/C87813604', 'wikidata': 'https://www.wikidata.org/wiki/Q1242899', 'display_name': 'Crossover study', 'level': 4, 'score': 0.4931957}, {'id': 'https://openalex.org/C97320921', 'wikidata': 'https://www.wikidata.org/wiki/Q718753', 'display_name': 'Drug interaction', 'level': 3, 'score': 0.43622681}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.36706287}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2902043}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.16692868}, {'id': 'https://openalex.org/C2779734285', 'wikidata': 'https://www.wikidata.org/wiki/Q11085', 'display_name': "Parkinson's disease", 'level': 3, 'score': 0.09938353}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.058588386}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C180754005', 'wikidata': 'https://www.wikidata.org/wiki/Q80726', 'display_name': 'Allele', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001577', 'descriptor_name': 'Benzophenones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D001577', 'descriptor_name': 'Benzophenones', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D002394', 'descriptor_name': 'Catechol O-Methyltransferase', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D007980', 'descriptor_name': 'Levodopa', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D007980', 'descriptor_name': 'Levodopa', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001577', 'descriptor_name': 'Benzophenones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002394', 'descriptor_name': 'Catechol O-Methyltransferase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007980', 'descriptor_name': 'Levodopa', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009596', 'descriptor_name': 'Nitrophenols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010599', 'descriptor_name': 'Pharmacokinetics', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013997', 'descriptor_name': 'Time Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077867', 'descriptor_name': 'Tolcapone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014838', 'descriptor_name': 'Volunteers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2125.1995.tb05781.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S13842274', 'display_name': 'British Journal of Clinical Pharmacology', 'issn_l': '0306-5251', 'issn': ['0306-5251', '1365-2125'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc1365105', 'pdf_url': 'https://europepmc.org/articles/pmc1365105?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1365105', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/8527287', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc1365105', 'pdf_url': 'https://europepmc.org/articles/pmc1365105?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.76, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 34, 'referenced_works': ['https://openalex.org/W1506736245', 'https://openalex.org/W1561054290', 'https://openalex.org/W1965754554', 'https://openalex.org/W1980384054', 'https://openalex.org/W1982924711', 'https://openalex.org/W1988277995', 'https://openalex.org/W2014601915', 'https://openalex.org/W2020613687', 'https://openalex.org/W2027221223', 'https://openalex.org/W2034816810', 'https://openalex.org/W2051557976', 'https://openalex.org/W2057232876', 'https://openalex.org/W2058662668', 'https://openalex.org/W2067324181', 'https://openalex.org/W2069981464', 'https://openalex.org/W2080126151', 'https://openalex.org/W2084633854', 'https://openalex.org/W2085965461', 'https://openalex.org/W2089182747', 'https://openalex.org/W2089597021', 'https://openalex.org/W2118896395', 'https://openalex.org/W2144727555', 'https://openalex.org/W2227046083', 'https://openalex.org/W2239722532', 'https://openalex.org/W2323830726', 'https://openalex.org/W2330445375', 'https://openalex.org/W2407776342', 'https://openalex.org/W2411729407', 'https://openalex.org/W2416937170', 'https://openalex.org/W245866583', 'https://openalex.org/W2502670554', 'https://openalex.org/W3215454188', 'https://openalex.org/W4210995338', 'https://openalex.org/W4246076186'], 'related_works': ['https://openalex.org/W9620540', 'https://openalex.org/W4307658853', 'https://openalex.org/W2133840774', 'https://openalex.org/W2115601613', 'https://openalex.org/W2095754699', 'https://openalex.org/W2083033452', 'https://openalex.org/W2017055459', 'https://openalex.org/W1984702297', 'https://openalex.org/W1974546036', 'https://openalex.org/W1972666504'], 'abstract_inverted_index': {'1.': [0], 'Single': [1], 'oral': [2], 'doses': [3], 'of': [4, 20, 28, 41, 76, 90, 104, 117, 127, 146, 160, 166, 189, 194, 201], 'the': [5, 102, 108, 111, 143], 'catechol-O-methyltransferase': [6], '(COMT)': [7], 'inhibitor': [8], 'tolcapone': [9, 190], '(10-800': [10], 'mg)': [11], 'or': [12], 'placebo': [13], 'were': [14, 50, 72, 122], 'administered': [15], 'simultaneously': [16], 'with': [17, 54, 97, 192, 206], 'a': [18, 34, 85, 98, 125, 158, 164], 'dose': [19, 68, 126], 'levodopa/benserazide': [21], '100/25': [22], 'mg': [23, 130], 'to': [24, 176], 'seven': [25], 'sequential': [26], 'groups': [27], 'six': [29], 'healthy': [30], 'male': [31], 'subjects': [32], 'in': [33, 52, 57, 79, 93, 95, 101, 174, 197, 208], 'two-way': [35], 'crossover': [36], 'study.': [37], '2.': [38], 'Plasma': [39, 187], 'concentrations': [40, 188], 'tolcapone,': [42], 'its': [43], 'metabolite': [44], '3-O-methyltolcapone,': [45], 'levodopa': [46, 209], 'and': [47, 70, 87, 114, 153, 163, 199], '3-O-methyldopa': [48], '(3-OMD)': [49], 'determined': [51], 'conjunction': [53], 'COMT': [55, 91, 195], 'activity': [56, 92, 196], 'erythrocytes.': [58], '3.': [59], 'The': [60, 119, 137, 169], 'drug': [61, 138, 170], 'combination': [62], 'was': [63, 150, 180], 'well': [64], 'tolerated': [65], 'at': [66, 124, 183], 'all': [67], 'levels': [69], 'there': [71], 'no': [73, 140], 'signs': [74], 'indicative': [75], 'an': [77], 'increase': [78], 'dopaminergic': [80], 'stimulation.': [81], '4.': [82], 'Tolcapone': [83, 106, 149], 'caused': [84], 'rapid': [86], 'reversible': [88], 'inhibition': [89, 193], 'erythrocytes': [94, 198], 'parallel': [96], 'dose-dependent': [99], 'decrease': [100], 'formation': [103, 179], '3-OMD.': [105], 'increased': [107, 134], 'area': [109], 'under': [110], 'concentration-time': [112], 'curve': [113], 'elimination': [115], 'half-life': [116], 'levodopa.': [118, 147], 'maximum': [120, 144], 'effects': [121], 'obtained': [123], 'about': [128], '200': [129], 'when': [131], 'both': [132], 'parameters': [133], 'approximately': [135], 'twofold.': [136], 'had': [139], 'influence': [141], 'on': [142, 156], 'concentration': [145], '5.': [148], 'rapidly': [151], 'absorbed': [152], 'eliminated': [154], 'with,': [155], 'average,': [157], 'tmax': [159], '1.5': [161], 'h': [162], 't1/2': [165], '2.3': [167], 'h.': [168], 'showed': [171], 'dose-proportional': [172], 'pharmacokinetics,': [173], 'contrast': [175], '3-O-methyltolcapone': [177], 'whose': [178], 'relatively': [181], 'decreased': [182], 'higher': [184], 'doses.': [185], '6.': [186], 'correlated': [191], 'suppression': [200], '3-OMD': [202], 'levels,': [203], 'but': [204], 'not': [205], 'changes': [207], 'pharmacokinetics.': [210]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2134178274', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 2}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-08T19:39:33.249328', 'created_date': '2016-06-24'}